Background: Obesity is a major global health challenge with significant metabolic and cardiovascular consequences. Artificial intelligence (AI) offers novel opportunities for prediction, risk stratification, and management; however, the structural landscape of this research has not been comprehensively assessed. Methods: We conducted a bibliometric analysis of 5893 unique articles from 2015 to July 15 th , 2025, indexed in Web of Science and Scopus. We used R (Bibliometrix and Biblioshiny) and VOSviewer to evaluate publication trends, citations, collaborations, and thematic clusters. Data integrity was verified by dual review of 5% of studies. Results: Scientific output rose steadily, with a marked acceleration after 2019. Citation activity peaked in 2020, reflecting increased focus on digital health during the Coronavirus Disease 2019 (COVID-19) pandemic. Thematic mapping identified four main clusters: (1) AI in surgical outcomes, including bariatric surgery and risk prediction; (2) digital health and remote care; (3) conversational technologies like natural language processing and chatbots; and (4) precision health, focusing on personalized medicine and predictive analytics. Collaboration networks were sparse, with few prolific authors. Conclusions: AI research in obesity is expanding rapidly across diverse themes but remains fragmented. Strengthening interdisciplinary collaboration will be critical to maximize impact on obesity care and outcomes.
Background: Understanding nurses' awareness, experience, and recommendations regarding the prevention of patient falls during bariatric surgery is critical to strengthen patient safety and improve the quality of care. This study aimed to determine in depth the experiences of operating room (OR) nurses regarding patient falls during bariatric surgery and their opinions and suggestions for the prevention of patient falls. Materials and Methods: The study is qualitative. It was conducted with 14 OR nurses working in a hospital in Turkey. Data were collected through in-depth interviews using a semistructured questionnaire. MAXQDA Software, a qualitative data analysis tool, was used. Results: In the findings of the study, a total of 4 themes (attitudes toward patient falls, experiences during patient falls, situations affecting patient falls, and suggestions for preventing patient falls), 15 subthemes, and 23 codes were identified. Conclusions: It was determined that OR nurses who experienced patient falls were meticulous about taking precautions intraoperatively. During bariatric surgery, the patient should be immobilized, safe surgical equipment should be used, and health care professionals should be trained in this regard.
Background: Insulin-like growth factor-1 (IGF-1) plays a role in metabolism and immune regulation. Although obesity is associated with chronic inflammation, the relationship between IGF-1 levels and systemic inflammatory markers remains unclear. This study aimed to examine the association between IGF-1 levels, systemic inflammation, and metabolic comorbidities in individuals with obesity. Methods: This retrospective cross-sectional study included 214 adults with a BMI >= 35 kg/m(2) evaluated between June 2019 and March 2025. Participants were classified as low IGF-1 (standard deviation score [SDS] <= -2.0) or standard IGF-1 (-2.0 < SDS < 2.0). Clinical and laboratory data were analyzed, including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, systemic immune-inflammation index (SII), systemic inflammation response index, and systemic inflammation aggregate index. Results: Low IGF-1 was identified in 8.88% of patients. No differences were found between groups regarding diabetes, dyslipidemia, or hypertension. NLR (2.21 vs. 1.79; p = 0.005) and SII (614.6 vs. 521.8; p = 0.041) were significantly higher in the standard IGF-1 group. SII was positively correlated with systolic blood pressure, alanine aminotransferase, and insulin. IGF-1 SDS was not correlated with inflammatory markers. Conclusions: Lower IGF-1 levels were not associated with higher systemic inflammation. These findings highlight the heterogeneity of inflammatory responses in obesity and suggest the need for further research.
Objective: To evaluate whether preoperative Pain Catastrophizing Scale (PCS) scores predict postoperative pain, opioid use, and suboptimal early weight loss after sleeve gastrectomy. Methods: In this prospective single-center cohort, 80 adults undergoing laparoscopic sleeve gastrectomy completed PCS, Beck Depression, and Beck Anxiety inventories preoperatively. Pain was recorded using the Numeric Rating Scale (NRS) at several time points in the first 24 h; opioid consumption was converted to morphine equivalents. Weight loss was assessed at 6 months as percent excess weight loss (%EWL). Receiver-operating characteristic (ROC) analysis was performed to determine the optimal PCS threshold for identifying patients at risk of suboptimal early weight loss (%EWL < 60) at 6 months. Multivariable logistic regression analysis was performed adjusting for age, sex, body mass index (BMI), depression, and anxiety. Results: Higher PCS scores strongly correlated with NRS pain at all time points (Spearman correlation coefficient [r] >= 0.70 at 2 h and 8 h; p < 0.001) and greater opioid use. ROC analysis identified PCS of >= 26 as the optimal cut-off for predicting %EWL of <60 (p = 0.048). Patients with PCS of >= 26 achieved lower mean %EWL (69.7 +/- 19.5%) than those with PCS < 26 (77.7 +/- 15.0%). In multivariable logistic regression analysis, PCS of >= 26 was associated with increased odds of suboptimal early weight loss (OR = 3.27, 95% CI: 0.51-21.10); however, this association did not reach statistical significance after adjustment. Conclusion: High PCS scores identify patients at risk for severe early pain and suboptimal early weight loss trajectory. Routine PCS screening may guide targeted perioperative pain management and behavioral interventions to improve bariatric outcomes.
Background: Obesity is a multifactorial condition linked not only to physical health risks but also to signifi-cant psychological distress. Depression, weight-related experiential avoidance, and negative automatic thoughts are common in individuals seeking bariatric surgery, yet their interrelationships remain underexplored. Objective: This study aimed to examine the relationships between depressive symptoms, weight-related experiential avoidance, and negative automatic thoughts in individuals eligible for bariatric surgery. Methods: A total of 75 adult participants with a mean body mass index of 45.9 (SD: 6.13) who met clinical criteria for bariatric surgery were recruited from endocrinology and general surgery outpatient clinics. Participants completed the Beck Depression Inventory (BDI), the Automatic Thoughts Questionnaire (ATQ), and the Acceptance and Action Questionnaire for Weight-Related Difficulties-Revised (AAQW-R). Group comparisons were made based on BDI scores, and Pearson correlations and linear regression analyses were conducted. Results: Fifty-five (73.3%) of the participants reported clinically significant depressive symptoms. Significant group differences were found for ATQ, AAQW-R total, and its subscales related to self-stigma and life interference (p <0.05) between the depression group and the minimal or no depression group. Regression analysis showed that negative automatic thoughts (ATQ) significantly predicted depressive symptoms (b = 0.595, p <0.001). Conclusion: Negative automatic thoughts are a stronger predictor of depression than psychological inflexibility in bariatric surgery candidates. Interventions targeting maladaptive thinking patterns may improve psychological outcomes in this population.
Background:Bariatric surgery, particularly Roux-en-Y gastric bypass (RYGB), is an effective treatment for extreme obesity, but some patients experience inadequate weight loss or weight regain. This study aimed to identify blood biomarkers that predict effective weight loss following RYGB. Methods:A microarray profile (GSE83223) was utilized to identify differentially expressed genes (DEGs) that could preoperatively predict body mass index (BMI) reduction after RYGB. Thirteen patients were divided into two groups based on their postsurgery BMI reduction: high (group A, n = 4) and low (group B, n = 9). DEGs were identified based on significant log fold change (LFC) (p < 0.05, │LFC│>1). Analyses included data preprocessing, protein-protein interactions, gene ontology, pathway analysis, and identification of hub genes. Results:Notable DEGs before surgery included SEBOX, NOCT, and TYK2, primarily involved in chromosome organization and macromolecule metabolism. Seventeen genes were consistently down-regulated pre and postsurgery, with SNRPB and BCL11A showing the highest │LFC│. Transcription factors MYC and ATF2 were identified as upstream regulators of these DEGs. Conclusion:The expression levels of these genes may serve as prognostic indicators for predicting the efficacy of bariatric surgery in obese individuals, potentially guiding clinical decisions for improved outcomes.
Aim: This study evaluated the effects of omentopexy on postoperative nausea and vomiting (PONV) in the first 24 h after patients underwent laparoscopic sleeve gastrectomy (LSG).Methods: In this prospectively designed retrospective data analysis study, 200 patients who underwent LSG consecutively in our clinic between August 2023 and December 2023 were assigned to one of two groups: 100 patients with omentopexy and 100 patients without omentopexy. The patients' demographic data, Apfel scores, and PONV scales were collected prospectively by the service nurses and analyzed retrospectively. LSG was performed using the five-trocar technique with imbrications in all patients.Results: Among the 200 patients (100 with omentopexy, 100 without), the mean age was 38.9 +/- 10.1 years, the mean body mass index was 41.9 +/- 6.4 kg/m2, and 86.5% were female gender. The LSG with omentopexy group had a statistically significantly lower nausea score and less vomiting than the LSG without omentopexy group (p < 0.05), even though the LSG with omentopexy group's Apfel score was statistically higher than that of the other group. Furthermore, the duration of nausea was statistically significantly higher in the LSG without omentopexy group (p < 0.05).Conclusion: Omentopexy is commonly preferred by surgeons for diverse purposes, including reinforcement of the stapler line, reducing gastrointestinal symptoms after LSG, and preventing torsion or reflux. In our study, the nausea score, duration of nausea, and vomiting were statistically significantly lower in patients who underwent LSG with omentopexy, indicating that surgeons may use omentopexy to control early PONV after LSG.
Objective: To investigate the effectiveness of clinical Pilates exercises performed through telerehabilitation in individuals who had undergone bariatric surgery (BS). Design: This is a prospective randomized controlled trial. A total of 20 individuals who had undergone BS patients were randomly allocated to the clinical Pilates exercise group (CPEG) and the control group (CG). The CPEG underwent telerehabilitation-based clinical Pilates exercises under physiotherapist supervision, twice weekly for 6 weeks. The CG received online physical activity (PA) counseling. The primary outcome was the functionality, which was assessed using the Senior Fitness Test Battery (6-min walk test [6-MWT], chair stand test, 8-foot up and go test [8-FUGT], arm curl test, back scratch test, chair sit, and reach test). Secondary outcomes were muscle strength, core stability, body composition, pedometer-recorded PA level, obesity-specific quality of life (QoL), and health-related QoL. Results: At the end of the study, statistically significant improvements favoring the CPEG were observed in the 6-MWT distance, arm curl, 8-FUGT, lower trapezius and gluteus maximus muscle strength, core stabilization, metabolic age, step count, Obesity and Weight Loss Quality of Life Instrument, and Nottingham Health Profile. Conclusion: Clinical Pilates exercises performed through telerehabilitation provide improvement in the parameters of functionality, physical fitness, and QoL in individuals who have undergone BS.
Background: Postoperative cognitive dysfunction (POCD) is highly prevalent after bariatric surgery, particularly among patients with obesity. This study aims to assess whether single-dose preoperative modafinil enhances cognitive outcomes and prevents POCD in patients undergoing sleeve gastrectomy under general anesthesia. Methods: This randomized, double-blind trial included 80 adults scheduled for sleeve gastrectomy, who received either 200 mg oral modafinil or placebo before surgery. Cognitive and emotional function were evaluated using the Addenbrooke's Cognitive Examination (ACE), Mini-Mental State Examination (MMSE), and Depression Anxiety Stress Scale (DASS-21), with Bonferroni-adjusted significance thresholds. Results: Baseline cognitive impairment was highly prevalent (80% ACE < 88; 26.25% MMSE < 27). Both groups demonstrated significant postoperative improvement in global ACE scores, verbal fluency, and memory (all p < 0.001), but not in attention or visuospatial domains. The language domain improved significantly only in the modafinil group (p = 0.001). Critically, the modafinil group showed a 20% increase in patients achieving normal ACE scores and a 17.5% decrease in those with abnormal scores(p < 0.001), while changes in the placebo group were not significant. DASS-21 and MMSE scores remained stable, and adverse events were rare and mild. Conclusions: Sleeve gastrectomy led to robust cognitive improvement; single-dose modafinil provided categorical cognitive benefit but did not significantly impact global or emotional outcomes.
Methods: Weight and height data were collected for body mass index (BMI) calculation, using the night feeding questionnaires, the Pittsburgh Sleep Quality Index (PSQI), and an adapted questionnaire about the practice of physical activity (PA). The data were analyzed in Statistical Package for the Social Sciences, v. 24.0 (statistical significance p < 0.05). The research was approved by the Research Ethics Committee (No. 5.180.990). Results: A total of 125 adults were evaluated in the preoperative stage of bariatric surgery, with an average BMI 46.2 kg/m(2) (+/- 7.4), 51.2% were physically active, with an average practice of PA of 219 (+/- 128.8) min. It was observed that 14.4% of participants met criteria for suggestive night eating syndrome (NES) behavior and 72% of participants had poor sleep quality. The PSQI score was a predictor of NES symptoms, regardless of BMI and practice of PA (B = 0.788, 95% confidence interval = 0.548-1.028, p < 0.001). Level of Evidence: Level III, well-designed cohort or case-control analytic studies. Conclusion: Sleep quality was found to be a predictor of NES suggestive behavior.
Psychosocial assessments by behavioral health (BH) professionals before metabolic and bariatric surgery (MBS) are recommended by national guidelines. Accordingly, insurance companies often require patients to undergo psychosocial assessments before MBS. This paper reviews the historical evolution of the MBS psychosocial assessment, clarifies the role of BH professionals within the team before and after MBS, and describes strategies to effectively utilize psychosocial assessments to optimize patient outcomes. Authors conducted a manual search of the available literature and completed a narrative review. The original intent of the psychosocial assessment for MBS was to correlate psychiatric profiles to weight loss outcomes or identify which patients were predicted to succeed or “fail” after MBS. Historically, these evaluations were gatekeeping mechanisms, which invalidates the myriad ways that psychosocial assessments can identify and support patients. Controversy exists about the necessity of these evaluations, leading some MBS team members and patients to see it as an unavoidable “checkbox” with little clinical utility outcomes. Viewing the psychosocial assessment as a checkbox minimizes the potential benefits to patients and MBS team members. Additionally, it diminishes the expertise of BH professionals who are uniquely trained to support this patient population toward an optimal surgical outcome.
Objectives: This study aimed to assess the prevalence of depression, anxiety, perceived discrimination, and weight stigma among bariatric surgery candidates. Methods: This cross-sectional study was conducted from April to November 2024 at a tertiary care obesity treatment center using convenience sampling. Participants (N = 210) completed validated tools, including the Beck Anxiety Inventory, Beck Depression Inventory, Weight Self-Stigma Questionnaire, and a discrimination scale. Data were analyzed using descriptive statistics, independent group comparisons, correlation tests, and multivariate adjusted models. Results: The median age of participants was 39 years. Based on body mass index (BMI), patients were categorized into Group A (35-40, n = 75) and Group B (>40, n = 135). BMI was significantly associated with marital status (p = 0.049) and education level (p = 0.031). While 43.8% had no or minimal depression, 81.4% reported grade 2 anxiety. Group A showed significantly higher depression scores (p = 0.012), whereas severe anxiety was more frequent in Group B. Moderate discrimination and mild stigma were commonly reported. Adjusted analyses revealed positive correlations between BMI and both discrimination (rs = 0.33, p < 0.001) and stigma (rs = 0.23, p = 0.007). Conclusion: Psychological distress and perceived stigma are prevalent in candidates for bariatric surgery. It is recommended to implement psychosocial screening and provide targeted psychological interventions to improve mental health and postoperative outcomes among them.
Background: Patients with severe neurological obesity are at a significantly higher risk of difficult airway due to anatomical and physiological alterations, presenting critical challenges in clinical airway management. Guided by Benner's from Novice to Expert framework and Kolcaba's Comfort Theory, this review examines nursing strategies that enhance both technical competency and patient-centered care in difficult airway management. Methods: Using Benner's competency domains as an analytical lens, this review examines the impact of obesity on airway physiology, identifies challenges in current nursing practices, and explores the potential of emerging technologies in difficult airway management. Key aspects include airway assessment limitations, nursing intervention gaps, and advancements in technology-driven solutions. Results: Current nursing approaches often lack standardized protocols for assessing and managing difficult airways in this population. The integration of novel techniques, such as artificial intelligence-assisted airway assessment, advanced imaging, and individualized airway management strategies, shows promise in enhancing patient outcomes. Conclusion: Improving difficult airway nursing in neurological obesity requires the development of evidence-based nursing protocols, adoption of emerging technologies, and enhanced training for clinical nurses. Addressing these gaps can significantly improve airway safety and optimize patient care.
Background: Numerous studies have demonstrated that bariatric and metabolic surgery (BMS) is a safe and effective option for obese patients. In Japan, national health insurance has covered laparoscopic sleeve gastrectomy (LSG) since 2014, increasing the number of procedures performed. This study analyzed 31 patients who underwent LSG at Okayama University Hospital, a regional core medical institution, between 2017 and 2024, focusing on safety and efficacy.Results: The findings revealed no severe complications and indicated significant weight loss and improvements in various metabolic diseases. However, challenges such as weight regain and interruptions in patient follow-up were identified. The remission rates for type 2 diabetes, hypertension, and dyslipidemia were 25%, 28.6%, and 56.3%, respectively. The study also noted potential pitfalls in surgical techniques, highlighting the importance of experienced medical teams.Conclusion: Although the weight loss rate in this study was slightly lower than the national average, the results remained promising. A multidisciplinary approach, encompassing thorough preoperative evaluations and consistent postoperative follow-up, was essential for success. BMS is highly effective and stands out as one of the key treatments for obesity. The study concludes that our facility has successfully introduced safe and effective BMS in the regional hub hospital by adhering to established guidelines.
Introduction: Several international guidelines recommend venous thromboembolism (VTE) chemoprophylaxis post bariatric surgery, as these patients are at moderate to high risk of developing thrombosis. Nonetheless, there is no consensus on the agent to be used for these cases. Fondaparinux, an inhibitor of factor Xa, has been used for preventing VTE generally in postoperative patients, but no clear data about its role in bariatric patients.Aim of the Study: To study the efficacy and safety of Fondaparinux in prophylaxis against VTE in patients undergoing bariatric surgery.Patients and Methods: We reviewed the medical records of patients who underwent bariatric surgery in a main bariatric center between January 2015 and May 2019 and who received Fondaparinux for VTE prophylaxis. In our hospital protocol, we use pneumatic compression devices intraoperatively and Fondaparinux 2.5 mg subcutaneously once daily for 5 days starting 6 h postsurgery regardless of body mass index (BMI). Intraoperatively, we neither use hemostatic agents nor suture the staple line. We use abdominal drains in some, but not all cases.Results: We reviewed the files of 546 patients who received Fondaparinux postsurgery. 167 patients (30.5%) were males, while 379 patients were females (69.5%). The mean age was 34 years, and the mean BMI was 44.2. 206 had sleeve gastrectomy (37.7%), 286 one-anastomosis gastric bypass surgery (52.3%), 27 had Roux-En-Y (5%), and the remaining 27 patients (5%) had revisional surgery. 234 had patients had no drain placed (42.8%), while 296 had a drain for 1 day (54.2%), 13 had the drain for 2 days (2.3%), and three patients had a drain for 7 days (0.6%). Mean preoperative and postoperative hemoglobin was 12.56 and 12.28, respectively. Four patients (0.86%) had an increase in bloody drainage in the drain that stopped spontaneously without any need for blood transfusion or surgical intervention. No cases of VTE, bleeding requiring intervention, or mortality were reported during the 6-month follow-up.Conclusion: Fondaparinux, as a single daily dose for 5 days, seems to be safe and effective in patients with different BMIs after bariatric surgery. Further prospective studies are needed to determine its exact role and help establish clear guidelines.
Introduction: Despite surging interest in glucagon-like peptide-1 receptor agonist (GLP1RA), there are few data regarding how preoperative GLP1RA impacts postoperative outcomes after bariatric surgery. Methods: This is a retrospective cohort study comparing early and long-term total weight loss (TWL%) between adult patients with and without preoperative GLP1RA before bariatric surgery. Results: A total of 902 patients were included, with 561 (62.2%) patients having gastric bypass and the rest having sleeve gastrectomy. Among these, 19 patients had liraglutide and 10 had semaglutide before surgery. Patients who received GLP1RA experienced slightly greater preoperative weight loss (6.7 +/- 7.0% vs. 4.8 +/- 9.9%, p = 0.30). A trend toward higher 1- to 2-month weight loss with preop GLP1RA, which was only significant among sleeve gastrectomy patients, was observed, with TWL% being 17.6 +/- 7.4% vs. 11.4 +/- 6.4% (p < 0.01) and 21.9 +/- 7.6% vs. 17.1 +/- 7.0% (p = 0.03) at 1 and 2 months, respectively. This difference gradually diminished at 6 months (27.5 +/- 6.7% vs. 24.3 +/- 7.6%, p = 0.15), 1 year (31.8 +/- 7.7% vs. 28.3 +/- 9.5%, p = 0.23), and 2 years (30.2 +/- 8.2% vs. 28.2 +/- 10.3%, p = 0.23). Conclusions: Greater early weight loss after sleeve gastrectomy was observed among patients who had preoperative GLP1RA. It is worth considering continuing GLP1RA after sleeve gastrectomy for patients who are at high risk for insufficient weight loss.
Background: Early postoperative total weight loss percentage (TWL%) shows heterogeneous predictive value for subsequent outcomes, yet targeted management strategies remain challenging. Identifying distinct early weight loss trajectories could characterize high-risk populations for weight regain, enabling proactive interventions to optimize long-term outcomes.Methods: This prospective observational study was conducted from April 2023 to December 2024. Dynamic weight data were recorded at 1, 3, 6, and 18 months postoperatively; TWL% was calculated. Latent Growth Curve Modeling (LGCM) was used to construct early weight loss trajectory models. Logistic regression analyzed associations between early weight loss trajectories and weight regain risk.Results: A total of 215 patients were included in the study. Weight regain incidence was 23.26%. LGCM identified two TWL% trajectory groups: rapid weight loss group and slow weight loss group. Taking the slow weight loss group as reference, rapid weight loss group had significant lower risk in the incidences of weight regain [Odds ratio (OR) = 0.441, p = 0.044].Conclusion: Two distinct early postoperative weight loss trajectories were identified, with the rapid weight loss group demonstrating significantly lower weight regain at 18 months. Early weight loss patterns are correlated with medium-term outcomes through more effective resetting of body weight set points.
Introduction/Purpose: Sleeve gastrectomy has become a popular method of bariatric surgery. To accelerate recovery after surgery plays an important role in reducing the morbidity rates of these patients. This article aims to examine the effects of the use of different anesthesia methods on enhanced recovery after surgery (ERAS) protocols in patients undergoing laparoscopic sleeve gastrectomy.Materials and Methods: This retrospective observational study included 60 patients who underwent laparoscopic sleeve gastrectomy. Patients were divided into two groups as those who received sevoflurane + dexmedetomidine (Group 1) and those who received desflurane + dexmedetomidine (Group 2). The patients' intraoperative spirometric parameters, perioperative hemodynamic parameters, the amount of anesthetic agents used, postoperative recovery, and nausea-vomiting characteristics were compared.Results: It was observed that the amount of anesthetic used and its cost were significantly less in Group 1 (p = 0.000 and p = 0.001, respectively). The intraoperative dexmedetomidine requirement was observed to be significantly low in Group 1 (p = 0.006). In Group 1, the change in compliance with insufflation was significantly high, but no significant difference was observed in perioperative quality.Conclusion: In this study, we concluded that sevoflurane used for the maintenance of anesthesia in patients undergoing laparoscopic sleeve gastrectomy may have a significant effect on ERAS protocols by reducing the cost of intraoperative inhalation agents and the consumption of dexmedetomidine.
Background: Abdominoplasty is the most common body contouring procedure after bariatric surgery. Complications in postbariatric patients differ due to altered body composition and comorbidities. This study investigated postoperative complications and risk factors, particularly the effects of liposuction volume and psychiatric comorbidities. Methods: A retrospective cross-sectional study was conducted on patients who underwent abdominoplasty between 2018 and 2023. Variables analyzed included age, sex, body mass index (BMI), surgical resection weight, liposuction volume, rectus diastasis repair, psychiatric comorbidities, smoking status, and postoperative complications. Results: Among 124 patients (67 females, 57 males; mean age 38.99 years), those with a history of bariatric surgery (n = 62) had a higher prevalence of psychiatric comorbidities and rectus diastasis repair. Nonbariatric patients (n = 62) had a greater resection weight, increased liposuction volume, and a higher incidence of seroma. Seroma risk was significantly associated with liposuction volume (p = 0.002), BMI (p < 0.05), and smoking (p < 0.05). Psychiatric comorbidities correlated with prolonged wound healing (defined as >3 weeks to complete closure or requiring extended dressings) and higher seroma rates (p = 0.027). Conclusion: Complication rates in body contouring surgeries after bariatric surgery are influenced by body mass index, comorbidities, and surgical techniques. Despite higher complication rates, seroma incidence was lower in postbariatric patients, likely due to reduced liposuction volume and altered subcutaneous tissue composition. Comprehensive preoperative assessments are essential for optimizing outcomes.
Background: Bariatric surgical interventions lead to some nutritional changes in individuals in the postoperative period. This study aimed to determine the experiences of individuals undergoing bariatric surgery regarding their nutritional behaviors.Methods and Patients: This study was conducted as qualitative research with purposal sampling method in hermeneutical phenomenological design. Data were collected using a semi-structured interview form through in-depth interviews with 13 participants at a public hospital in T & uuml;rkiye between November 2021 and March 2023. Face-to-face interviews were audio-recorded and conducted until data saturation was reached. MAXQDA 2022 software was utilized to analyze the data. The study adhered to the consolidated criteria for reporting qualitative research checklist for reporting.Results: Through data analysis, four main themes (nutritional behavior after surgery, changes in eating behavior after surgery, challenges associated with bariatric surgery, and coping strategies) were created. The first main theme had two main themes and five subthemes. The second main theme had five subthemes. The third and fourth main themes had four subthemes.Conclusion: Our study highlights the changes in nutritional behavior, difficulties getting used to a new life, and coping mechanisms after bariatric surgery were clarified. Despite many changes and negative experiences, individuals developed coping strategies.
